# A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)

Source: https://onco.cc/trials/nct06835530/  
OnCo record `nct06835530` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Geriatric assessment in Non-Hodgkin lymphoma, run by Fondazione Italiana Linfomi - ETS, now recruiting.

## Summary

A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL) is a phase 2 interventional study registered as NCT06835530 by Fondazione Italiana Linfomi - ETS, with 47 participants planned, started 2025-04-09 and due to reach its primary completion in 2030-04. Interventions recorded: Rituximab + Golcadomide (CC-99282). Conditions recorded: Diffuse Large B Cell Non-Hodgkin Lymphoma.

Linked to the technology Geriatric assessment because the registry's title names it ("geriatric assessment") and Non-Hodgkin lymphoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06835530
- Phase: 2
- Setting: A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
- Sponsor: Fondazione Italiana Linfomi - ETS
- Enrolled: 47

## Sources

- ClinicalTrials.gov NCT06835530: https://clinicaltrials.gov/study/NCT06835530

## Connected records

- cancers: [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)
- technologies: [Geriatric assessment](https://onco.cc/technologies/geriatric-assessment/)
- drugs: [Golcadomide](https://onco.cc/drugs/golcadomide/)

---
JSON: https://onco.cc/api/v1/entities/nct06835530.json